FDA Inspection 1247249 — Elyse S. Rafal, M.D.
The FDA completed an inspection of Elyse S. Rafal, M.D. on August 1, 2024 in Stony Brook, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 1, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Stony Brook, NY (United States)
Additional Details
Clinical BA/BE